Living Cell Technologies Diabecell Phase II Trial Receives Approval To Progress In New Zealand
Diabecell is LCT’s treatment designed to normalise the lives of people with insulin-dependent diabetes. Diabecell comprises encapsulated porcine islets (insulin-producing cells) that are implanted into the abdomen of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.